Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Foghorn Therapeutics (FHTX) Tax Provisions (2023)

Foghorn Therapeutics (FHTX) has 1 years of Tax Provisions data on record, last reported at $2.0 million in Q4 2023.

  • For Q4 2023, Tax Provisions changed N/A year-over-year to $2.0 million; the TTM value through Sep 2024 reached $2.0 million, down 11.34%, while the annual FY2023 figure was $4.2 million, N/A changed from the prior year.
  • Tax Provisions reached $2.0 million in Q4 2023 per FHTX's latest filing, up from $738000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $2.0 million in Q4 2023 and bottomed at $560000.0 in Q1 2023.